《公司業績》奇富科技(03660.HK)第三季普通股股東應佔淨利潤11.42億元人幣 按年升15%
奇富科技-S(03660.HK)公布截至今年9月底止第三季業績,淨收入總額42.81億元人民幣(下同),按年升3.3%,普通股股東應佔淨利潤11.42億元,按年升15%,每股盈利3.56元。
首三季淨收總額117.95億元,按年跌6.7%。普通股股東應佔淨利潤 31.74億元,按年升0.7%;每股盈利9.85元。
奇富科技首席執行官兼董事吳海生表示,第三季度撮合和發放的貸款總額1,231億元,按年增長11.3%。約56%的貸款通過輕資本模式、ICE和其他技術解決方案所提供。季度新增授信用戶數超過170萬,期內新增ABS發行推動總體資金成本再創新低。(cy/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.